Insmed Inc INSM Stock Forecast
AI-powered price prediction and analysis for Insmed Inc ยท Updated Sep 25, 2026
See INSM's Exact Price Target
Create a free account and follow this stock to unlock its full AI forecast โ 3 stocks free.
Sign Up Free with GooglePrice Chart
Key Statistics
About Insmed Inc
Insmed Inc (INSM) operates in the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. .
Latest News
Where INSM sits on the market map
Pharmaceutical Preparations Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | Ticker | AI Signal | Market Cap | P/E |
|---|---|---|---|---|
| Insmed Inc | INSM | โโ% | $26.54B | -x |
| Eli Lilly & โฆ | LLY | โโ% | $1.08T | 40.6x |
| Johnson & Johnson | JNJ | โโ% | $652.31B | 31.0x |
| Beone Medicines Ltd. | ONC | โโ% | $539.52B | -x |
| Abbvie Inc. | ABBV | โโ% | $468.43B | 74.2x |
| Merck & Co., โฆ | MRK | โโ% | $365.34B | 115.1x |
| Novartis Ag | NVS | โโ% | $272.31B | -x |
| Gsk Plc | GSK | โโ% | $214.26B | -x |
| Abbott Laboratories | ABT | โโ% | $180.26B | 28.6x |
| Pfizer Inc | PFE | โโ% | $160.62B | 37.1x |
| Vertex Pharmaceuticals Inc โฆ | VRTX | โโ% | $130.87B | 29.7x |
| Bristol Myers Squibb โฆ | BMY | โโ% | $125.63B | 13.5x |
| Regeneron Pharmaceuticals, Inc. | REGN | โโ% | $82.55B | 19.1x |
| Sanofi | SNY | โโ% | $50.80B | -x |
| Teva Pharmaceutical Industries โฆ | TEVA | โโ% | $45.46B | 64.3x |
| Alnylam Pharmaceuticals, Inc. | ALNY | โโ% | $33.40B | -x |
| Royalty Pharma Plc | RPRX | โโ% | $33.15B | 40.7x |
| Alterity Therapeutics Ltd | ATHE | โโ% | $32.40B | -x |
| Takeda Pharmaceutical Co โฆ | TAK | โโ% | $29.93B | -x |
| Zai Lab Ltd | ZLAB | โโ% | $29.68B | -x |
| Zoetis Inc. | ZTS | โโ% | $29.59B | 11.3x |
| Roivant Sciences Ltd. | ROIV | โโ% | $26.60B | -x |
| United Therapeutics Corp | UTHR | โโ% | $20.99B | 16.0x |
| Viatris Inc | VTRS | โโ% | $19.66B | -x |
| Jazz Pharmaceuticals Plc | JAZZ | โโ% | $15.34B | 16.3x |
| Ascendis Pharma A/S | ASND | โโ% | $14.30B | -x |
| Summit Therapeutics Inc. | SMMT | โโ% | $13.12B | -x |
| Bridgebio Pharma, Inc. | BBIO | โโ% | $12.96B | -x |
| Corcept Therapeutics Inc | CORT | โโ% | $12.81B | -x |
| Hutchmed (China) Ltd | HCM | โโ% | $12.13B | -x |
| Biomarin Pharmaceutical Inc | BMRN | โโ% | $11.88B | -x |
| Kiniksa Pharmaceuticals International, โฆ | KNSA | โโ% | $11.87B | -x |
| Madrigal Pharmaceuticals, Inc. | MDGL | โโ% | $11.86B | -x |
| Elanco Animal Health โฆ | ELAN | โโ% | $11.17B | -x |
| Dr Reddys Laboratories โฆ | RDY | โโ% | $10.34B | -x |
| Axsome Therapeutics, Inc. | AXSM | โโ% | $10.27B | -x |
| Arrowhead Pharmaceuticals, Inc. | ARWR | โโ% | $9.33B | -x |
| Cytokinetics Inc | CYTK | โโ% | $9.13B | -x |
| Protagonist Therapeutics, Inc | PTGX | โโ% | $8.98B | -x |
| Praxis Precision Medicines, โฆ | PRAX | โโ% | $7.88B | -x |
| Spyre Therapeutics, Inc. | SYRE | โโ% | $7.77B | -x |
| Structure Therapeutics Inc. | GPCR | โโ% | $7.71B | -x |
| Abivax S.A. | ABVX | โโ% | $7.39B | -x |
| Ionis Pharmaceuticals Inc | IONS | โโ% | $7.28B | -x |
| Alkermes Plc. | ALKS | โโ% | $6.84B | -x |
| Legend Biotech Corp | LEGN | โโ% | $6.82B | -x |
| Rhythm Pharmaceuticals, Inc. | RYTM | โโ% | $6.76B | -x |
| Biolinerx Ltd. | BLRX | โโ% | $6.68B | -x |
| Belite Bio, Inc | BLTE | โโ% | $6.67B | -x |
| Amneal Pharmaceuticals, Inc. | AMRX | โโ% | $6.32B | -x |
| Liquidia Corp | LQDA | โโ% | $6.04B | -x |
| Ligand Pharmaceuticals Inc | LGND | โโ% | $5.96B | 30.2x |
| Mirum Pharmaceuticals, Inc. | MIRM | โโ% | $5.80B | -x |
| Amarin Corp Plc\Uk | AMRN | โโ% | $5.64B | -x |
| Travere Therapeutics, Inc. | TVTX | โโ% | $5.64B | -x |
| Cogent Biosciences, Inc. | COGT | โโ% | $5.45B | -x |
| Ptc Therapeutics, Inc. | PTCT | โโ% | $5.20B | -x |
| Erasca, Inc. | ERAS | โโ% | $5.08B | -x |
| Dianthus Therapeutics, Inc. โฆ | DNTH | โโ% | $5.07B | -x |
| Viking Therapeutics, Inc. | VKTX | โโ% | $4.86B | -x |
FAQ
-
Is Insmed Inc a good stock to buy?
Our AI analyzes Insmed Inc daily. Check the signal above for the latest recommendation. Always do your own research before investing.
-
How accurate are Insmed Inc predictions?
A per-ticker accuracy statistic for INSM is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
-
How often are forecasts updated?
Insmed Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on September 25, 2026.
Ready to invest smarter?
Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Insmed Inc?
View full institutional-grade analysis on Intratio โAI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.